Aerovate Therapeutics Inc Stock

$2.52

0.00% today

Nasdaq, Apr 03, 06:50 pm CET

ISIN

US0080641071

Symbol

AVTE

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Aerovate Therapeutics Inc Stock price

$2.52

-20.31 88.96% 5Y

Nasdaq, Closing price Wed, Apr 02 2025

+0.01 0.40%

ISIN

US0080641071

Symbol

AVTE

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Key metrics

Market capitalization	$73.04m
Enterprise Value	$-5.16m
P/E (TTM) P/E ratio	negative
EV/FCF (TTM) EV/FCF	0.07
P/B ratio (TTM) P/B ratio	0.96
Revenue (TTM) Revenue	$0.00
EBIT (operating result TTM) EBIT	$-74.60m
Free Cash Flow (TTM) Free Cash Flow	$-71.20m
Cash position	$78.62m
EPS (TTM) EPS	$-2.45
P/E forward	negative
Short interest	37.64%

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Get Started for Free Today

Aerovate Therapeutics Inc Stock Analysis

Unlock Scores for Free

??

2 Analysts have issued a Aerovate Therapeutics Inc forecast:

2x Hold

100%

More details on Analyst Estimates Including Price Targets

2 Analysts have issued a Aerovate Therapeutics Inc forecast:

Hold

100%

Analyst Estimates with Stock Price Targets

Financial data from Aerovate Therapeutics Inc

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Dec '24		+/- %
Revenue	- -	- 100%
- Direct Costs	0.28 0.28	180% 180% -
Gross Profit	-0.28 -0.28	180% 180% -
- Selling and Administrative Expenses	21 21	23% 23% -
- Research and Development Expense	53 53	17% 17% -
EBITDA	-74 -74	9% 9% -
- Depreciation and Amortization	0.28 0.28	180% 180% -
EBIT (Operating Income) EBIT	-75 -75	8% 8% -
Net Profit	-70 -70	8% 8% -

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Aerovate Therapeutics Inc Stock News

Neutral

Business Wire

●

13 days ago

AEROVATE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerovate Therapeutics, Inc. - AVTE

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Aerovate Therapeutics, Inc. (NasdaqGM: AVTE) and Jade Biosciences. Pursuant to the terms of the agreement, shareholders of Aerovate will own approximately 1.6% of the combined company. KSF is see...

Neutral

Business Wire

●

3 months ago

AVTE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aerovate Therapeutics, Inc. Is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Aerovate Therapeutics, Inc. (NASDAQ: AVTE) and Jade Biosciences is fair to Aerovate shareholders. Upon closing of the proposed transaction, Aerovate stockholders are expected to own approximately 1.6% of the combined company. Halper Sadeh encourages Aerovate shareholders to click her...

Neutral

Business Wire

●

5 months ago

AEROVATE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerovate Therapeutics, Inc. - AVTE

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Aerovate Therapeutics, Inc. (NasdaqGM: AVTE) and Jade Biosciences. Pursuant to the terms of the agreement, shareholders of Aerovate will own approximately 1.6% of the combined company. KSF is seeking to determin...

More Aerovate Therapeutics Inc News

Company Profile

Aerovate Therapeutics, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focus on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was founded by Benjamin T. Dake in July 27, 2018 and is headquartered in Boston, MA.

Head office	United States
CEO	Timothy Noyes
Employees	30
Founded	2018
Website	www.aerovatetx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now